Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naive patients >= 65 years with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) Meeting Abstract


Authors: Dubowy, R.; O'Brien, S.; Lamanna, N.; Kipps, T.; Flinn, I.; Zelenetz, A.; Burger, J.; Holes, L.; Cho, Y.; Coutre, S.
Abstract Title: Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naive patients >= 65 years with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Meeting Title: 55th Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 169
Issue: Suppl. 1
Meeting Dates: 2015 Apr 20-22
Meeting Location: Edinburgh, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2015-04-01
Start Page: 57
Language: English
ACCESSION: WOS:000353231200137
PROVIDER: wos
PUBMED: 25891202
DOI: 10.1111/bjh.13350
Notes: Meeting Abstract: 136 -- 55th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 20-22, 2015 -- Edinburgh, SCOTLAND -- 1 -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work